99.89

2.17% 2.53

Medtronic Plc (MDT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Medtronic Plc stock is traded at $99.89, with a volume of 437.73K. It is up +2.17% in the last 24 hours and down -1.86% over the past month. One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Previous Close:

$97.36

Open:

$98.06

24h Volume:

437.73K

Relative Volume:

0.07

Market Cap:

$127.88B

Revenue:

$34.76B

Net Income/Loss:

$4.79B

P/E Ratio:

26.98

EPS:

3.7017

Net Cash Flow:

$5.21B

1W Performance:

+2.91%

1M Performance:

-1.86%

6M Performance:

+12.54%

1Y Performance:

+24.59%

1-Day Range:

$97.71

$99.75

1-Week Range:

$95.17

$99.72

52-Week Range:

$79.55

$106.33

Medtronic Plc Stock (MDT) Company Profile

Name

Medtronic Plc

Sector

Healthcare (1119)

Industry

Medical Devices (144)

Phone

01135314381700

Address

BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY

Employee

95,000

Twitter

@Medtronic

Next Earnings Date

2025-08-19

Latest SEC Filings

MDT's Discussions on Twitter

Compare MDT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDT Medtronic Plc	99.75	124.82B	34.76B	4.79B	5.21B	3.7017
ABT Abbott Laboratories	128.41	219.88B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	96.54	141.54B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	355.37	133.39B	24.38B	2.94B	4.07B	7.6159
EW Edwards Lifesciences Corp	85.69	48.84B	5.88B	1.34B	799.60M	2.3489

Medtronic Plc Stock (MDT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-19-25	Upgrade	Goldman	Sell → Neutral
Jun-30-25	Upgrade	Wolfe Research	Underperform → Peer Perform
Jun-16-25	Initiated	Leerink Partners	Outperform
Mar-04-25	Upgrade	Citigroup	Neutral → Buy
Oct-10-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Aug-21-24	Reiterated	Oppenheimer	Perform
Aug-15-24	Upgrade	UBS	Sell → Neutral
Aug-14-24	Downgrade	Stifel	Buy → Hold
May-30-24	Initiated	Goldman	Sell
Jul-19-23	Initiated	Robert W. Baird	Neutral
Jun-30-23	Initiated	CL King	Buy
May-30-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-24-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Mar-29-23	Downgrade	UBS	Buy → Sell
Jan-09-23	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-23-22	Downgrade	Citigroup	Buy → Neutral
Nov-23-22	Downgrade	Oppenheimer	Outperform → Perform
Nov-16-22	Downgrade	Deutsche Bank	Buy → Hold
Oct-18-22	Initiated	Barclays	Equal Weight
Oct-13-22	Initiated	Mizuho	Buy
Oct-12-22	Initiated	Jefferies	Hold
Aug-24-22	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-06-22	Initiated	Wolfe Research	Underperform
Jun-01-22	Downgrade	Atlantic Equities	Overweight → Neutral
May-27-22	Downgrade	Needham	Buy → Hold
Apr-13-22	Downgrade	Truist	Buy → Hold
Mar-02-22	Resumed	BofA Securities	Buy
Jan-10-22	Downgrade	BTIG Research	Buy → Neutral
Jan-07-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-04-22	Downgrade	Piper Sandler	Overweight → Neutral
Dec-17-21	Downgrade	JP Morgan	Overweight → Neutral
Dec-16-21	Downgrade	Wells Fargo	Overweight → Equal Weight
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
Jun-10-21	Resumed	Cowen	Outperform
May-25-21	Initiated	Barclays	Equal Weight
Apr-15-21	Initiated	Atlantic Equities	Overweight
Dec-15-20	Upgrade	Goldman	Sell → Neutral
Dec-15-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-08-20	Upgrade	Bernstein	Mkt Perform → Outperform
Oct-08-20	Upgrade	Stifel	Hold → Buy
Sep-11-20	Initiated	Wolfe Research	Peer Perform
May-14-20	Downgrade	DZ Bank	Buy → Hold
Mar-30-20	Downgrade	Needham	Strong Buy → Buy
Mar-25-20	Upgrade	DZ Bank	Hold → Buy
Mar-05-20	Initiated	Citigroup	Buy
Feb-13-20	Initiated	Goldman	Sell
Jan-08-20	Initiated	SunTrust	Buy
Jan-02-20	Upgrade	Guggenheim	Neutral → Buy
Jun-05-19	Upgrade	Wells Fargo	Market Perform → Outperform
Feb-04-19	Reiterated	Needham	Strong Buy
Jan-03-19	Initiated	Deutsche Bank	Buy
Jan-02-19	Downgrade	Citigroup	Buy → Neutral
Dec-19-18	Upgrade	JP Morgan	Neutral → Overweight
Nov-28-18	Initiated	UBS	Buy
Oct-16-18	Initiated	Barclays	Overweight
Aug-27-18	Reiterated	Argus	Buy

View All

Medtronic Plc Stock (MDT) Latest News

05:54 AM

William Blair upgrades Medtronic stock rating to Outperform from Market Perform - Investing.com UK

05:54 AM

05:50 AM

The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson - The Globe and Mail

05:50 AM

04:16 AM

Commonwealth Equity Services LLC Reduces Stock Holdings in Medtronic PLC $MDT - MarketBeat

04:16 AM

02:30 AM

2 Soaring Stocks to Hold for the Next 20 Years - The Motley Fool

02:30 AM

Jan 05, 2026

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference - PR Newswire

Jan 05, 2026

Medtronic Benefits Are Built for Every Chapter - CSRwire

Jan 05, 2026

Medtronic stock holds steady as Piper Sandler maintains Neutral rating By Investing.com - Investing.com UK

Jan 05, 2026

D.A. Davidson & CO. Has $20.33 Million Holdings in Medtronic PLC $MDT - MarketBeat

Jan 05, 2026

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly - simplywall.st

Jan 05, 2026

The Truth About Medtronic plc: Is This ‘Boring’ Stock Actually a Silent Flex? - AD HOC NEWS

Jan 05, 2026

Jan 04, 2026

Asset Management One Co. Ltd. Has $56.11 Million Stake in Medtronic PLC $MDT - MarketBeat

Jan 04, 2026

Davis Capital Management Makes New $1.26 Million Investment in Medtronic PLC $MDT - MarketBeat

Jan 04, 2026

Capital Advisors Inc. OK Raises Stake in Medtronic PLC $MDT - MarketBeat

Jan 04, 2026

Jan 03, 2026

Synergy Asset Management LLC Acquires 128,899 Shares of Medtronic PLC $MDT - MarketBeat

Jan 03, 2026